NeurAxis Announces Additional Medical Policy Coverage For PENFS Representing Over 500,000 Covered Lives, Expanding IB-Stim Access In Mid-Atlantic Region
Share
Why It Matters
NeurAxis got approval for its product to be covered by more insurance plans for over 500,000 people in the Mid-Atlantic area. When more insurance companies cover a medical product, it usually means more patients can afford to use it, which could help the company's business grow.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.